BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Abcam plc (ABC.L) Notification of Preliminary Results


8/19/2011 9:25:29 AM

August 19, 2011 -- Abcam plc (AIM: ABC), a global leader in the supply of protein research and detection tools, will announce its preliminary results for the 12 months ended 30 June 2011 on Tuesday 13 September 2011.

An analyst meeting will be held at 10.30am on Tuesday 13 September at the offices of Buchanan Communications, 107 Cheapside, London EC2V 6DN.

For further information please contact:

Abcam + 44 (0) 1223 696000

Jonathan Milner, Chief Executive Officer

Jeff Iliffe, Chief Financial Officer

www.abcamplc.com

Numis Securities + 44 (0) 20 7260 1000

Michael Meade – Nominated Adviser

James Black – Corporate Broking

Buchanan Communications + 44 (0) 20 7466 5000

Mark Court / Jessica Fontaine

About Abcam plc

Abcam is a producer and distributor of high quality research-grade antibodies and associated proteomics research products. Antibodies and related products are essential tools for life scientists enabling them to analyse components of living cells at the molecular level.

Headquartered in Cambridge (UK), Abcam has subsidiary offices in Cambridge, Massachusetts, and Eugene, Oregon (USA), Tokyo (Japan) and Hong Kong (China) allowing them to serve a global customer base of 75 countries. Abcam employs over 325 staff across its five operating companies.

Abcam now has an online catalogue of over 74,000 products sourced from over 250 suppliers. The catalogue includes a growing range of non-antibody products such as proteins, peptides, lysates, immunoassays and other kits. Products are available for life science research and distributed to academic and commercial users. A highly developed e-commerce platform, which includes regional websites for the Chinese and Japanese markets, allows customers to access up-to-date and detailed technical product data sheets at the Company's website www.abcam.com.

Abcam was admitted to AIM in November 2005 and trades under the ticker symbol ABC. The Company's vision is to be the leading provider of protein research and detection tools globally.



Read at BioSpace.com

Abcam plc
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES